撒哈拉以南非洲2型糖尿病与高血压患者用药、生活方式建议及自我监测依从性:系统综述、荟萃分析与交互网络分析
该系统综述与荟萃分析纳入312项研究、108,014名来自28个国家的成人患者,评估撒哈拉以南非洲2型糖尿病和高血压患者对用药、生活方式建议及自我监测的依从性。汇总依从率从血糖监测的18%到戒烟95%不等,总体自我管理依从率在2型糖尿病为37%、高血压为35%。教育、自我效能和社会支持是与依从性最一致的交叉决定因素。
要点
- 抗糖尿病药物汇总依从率为67%,抗高血压药物为51%。
- 饮食建议依从率44%,体力活动42%,血糖监测仅18%。
- 总体自我管理依从率:2型糖尿病37%,高血压35%。
核心结论
- 撒哈拉以南非洲2型糖尿病和高血压患者在各治疗支柱上的依从性均不理想。
- 教育、自我效能和社会支持是未来改善依从性干预研究的优先候选决定因素。
研究设计与样本
- 系统综述与荟萃分析,检索六个学术数据库及Google Scholar,纳入2004年1月1日至2026年5月14日发表的观察性和干预性研究。
- 纳入312项研究、108,014名来自28个国家的成人2型糖尿病或高血压患者。
- 采用随机效应模型合并依从比例,并进行亚组分析和荟萃回归;使用交互网络分析及noteworthiness评分识别交叉决定因素。
- 偏倚风险采用Newcastle-Ottawa量表和Cochrane RoB 2评估。
- 研究注册于PROSPERO(CRD42024626793)。
主要发现
- 抗糖尿病药物汇总依从率为67%(95%CI [60, 73])。
- 抗高血压药物汇总依从率为51%(95%CI [44, 58])。
- 饮食建议依从率44%(95%CI [38, 49]),体力活动42%(95%CI [37, 47])。
- 酒精戒断依从率85%(95%CI [82, 88]),戒烟95%(95%CI [94, 96])。
- 血糖监测依从率18%(95%CI [12, 27]),血压监测28%(95%CI [16, 45])。
临床怎么用
- 临床应关注用药、生活方式建议及自我监测各支柱的依从性评估。
- 教育、自我效能和社会支持可作为改善依从性的干预靶点。
局限性
- 统计异质性高(I2 > 95%,p < 0.001),尽管采用随机效应模型和亚组分析仍持续存在。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 2 diabetes and hypertension are major public health challenges in sub-Saharan Africa, yet treatment control remains poor. Patient adherence to key treatment pillars (medication, lifestyle advice, and self-monitoring) is essential for treatment control, yet adherence across these pillars has not been comprehensively synthesized. We conducted a systematic review and meta-analysis to map adherence to medication, lifestyle advice, and self-monitoring for type 2 diabetes and hypertension in sub-Saharan Africa, and applied a network analysis to identify cross-cutting determinants as priority candidates for future interventional studies. METHODS AND FINDINGS: We searched six academic databases, and Google Scholar, for observational and interventional studies in adults with type 2 diabetes or hypertension in sub-Saharan Africa published between January 1, 2004, and May 14, 2026. Risk of bias was assessed using Newcastle-Ottawa Scale and Cochrane RoB 2. We used random-effects models to pool adherence proportions and conducted subgroup analyses and meta-regressions. Cross-cutting determinants were identified using interactive network analysis with noteworthiness scores. We included 312 studies with 108,014 participants from 28 countries. Pooled adherence was 67% (95% CI [60, 73]) for antidiabetic medications, 51% (95% CI [44, 58]) for antihypertensive medications, 44% (95% CI [38, 49]) for dietary recommendations, 42% (95% CI [37, 47]) for physical activity, 85% (95% CI [82, 88]) for alcohol abstinence, 95% (95% CI [94, 96]) for smoking cessation, 18% (95% CI [12, 27]) for glucose monitoring, and 28% (95% CI [16, 45]) for blood pressure monitoring. Overall self-care adherence was 37% (95% CI [30, 46]) for type 2 diabetes and 35% (95% CI [29, 42]) for hypertension. Heterogeneity was high (I2 > 95%, p < 0.001 throughout). Education, self-efficacy, and social support emerged as cross-cutting determinants most consistently associated with adherence. A key limitation is the high statistical heterogeneity, which persisted despite random-effects modeling and subgroup analyses. CONCLUSIONS: Adherence across treatment pillars is suboptimal. Education, self-efficacy, and social support represent priority candidates for future interventional studies aimed at improving adherence. The review was registered with PROSPERO (CRD42024626793).
引用
- Apostolou A, Simfukwe R, Saint A, et al. Adherence to medications, lifestyle advice, and self-monitoring for type 2 diabetes and hypertension in sub-Saharan Africa: A systematic review, meta-analysis, and interactive network analysis. PLoS Med. 2026. PMID: 42546023. doi:10.1371/journal.pmed.1005189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。